Need pharma insights? Register for Evaluate Discovery
Need pharma insights? Register for Evaluate Discovery
Our training programs help forecasting teams build the skills they need to deliver high-impact insights. From foundational techniques to hands-on model building, we provide practical, expert-led learning designed to elevate forecasting performance across the organization.
No two forecasting challenges are the same. Our experienced consulting team provides tailored, scalable support—whether you need help validating assumptions, building models, or aligning global teams. We can provide structure and expertise when it matters most, from early pipeline planning through launch and lifecycle management.
Data is the cornerstone of confident forecasting. Evaluate integrates robust, multi-sourced data—ranging from epidemiology to clinical and commercial intelligence—to ensure every input is trusted, validated, and benchmarked. Our proprietary datasets, analyst insights, and real-world metrics bring unparalleled clarity to both early-stage assessments and in-market brand forecasts.
Forecasting models must be both robust and adaptable. We help you build and deploy models that suit your specific portfolio needs—whether that’s through standard frameworks, AI-augmented tools, or fully custom designs. We support model evolution from preclinical planning to mature brand management, ensuring you’re equipped for every stage of the product lifecycle.
Gain deeper insights and more accurate predictions for strategic portfolio decisions with extensive analyst-driven forecasts, broker forecasts, cutting-edge machine learning approaches, custom forecast models, and proprietary analogues and benchmarks.
Track disease stages, sub-populations, and treatment flow, and benchmark your forecasts against potential and addressable market data. Estimate drug-related populations with bottom-up forecasting to understand population evolution, validate investments and identify growth opportunities.
Gain control of your opportunity portfolio and drive launch success with optimised market entry strategies. Our strategic approach, industry expertise, and launch-ready models maximise market impact, helping you navigate the complexities of product launch.
Achieve connected forecasting across global teams with consistent models and forecasting processes that ensure accurate, actionable brand forecasts aligned with your strategy. Blend best practices with proven methodologies to enhance decision-making and drive better business outcomes.
Catch up with our latest forecasting insights
Report/eBook
7 Jan 2026
2026 Preview: Navigating Pharma’s Critical Year The biopharma sector enters 2026 in qualified recovery. After years of tough financing and investor skepticism, green shoots are…
Article
14 Oct 2025
Artificial Intelligence (AI) is empowering pharma companies to make smarter, faster, and more confident decisions. In this must-read article we explore the real-world impact of…
Infographic
13 Oct 2025
95% of pharma companies are investing in AI – but the real transformation is still to come. Artificial Intelligence (AI) isn’t just changing how drugs…
Report/eBook
1 Oct 2025
The pharmaceutical industry is at a turning point. Pharma v Biotech: New Rules? explores how pricing pressures, policy shifts, and the rise of consumer influence…
Article
26 Sep 2025
Unlock exclusive insights into the forces reshaping the biopharma industry. The boundaries between pharma and biotech are becoming less distinct, and there is a growing…
Report/eBook
22 Aug 2025
A practical guide to understanding sales forecasting methods, data sources, and eventing in pharma. Accurate pharmaceutical sales forecasting is essential for making confident business decisions…
Report/eBook
30 Jul 2025
As pipeline competition intensifies and lifecycle timelines shorten, we are seeing pharmaceutical forecasting teams being asked to do more, with less time and greater uncertainty….
Report/eBook
17 Jun 2025
Despite policy uncertainty, regulatory flux, and shifting global dynamics, the pharmaceutical industry is on track to surpass $1.75 trillion in prescription drug sales by the…
Report/eBook
28 May 2025
Whether you are focused on epidemiology-based models, patient flow frameworks, or sales-driven forecasting, mastering your methodology is key to producing credible, strategic forecasts. At any…
Blog
23 Apr 2025
For Portfolio Strategy teams in pharma companies, there is a constant juggling act to ensure that the right therapies are being prioritized for the right…
Blog
10 Apr 2025
Having good forecast models is critical for effective and efficient decision-making. This will deliver accurate and reliable insights to help support business objectives and drive…
Report/eBook
14 Mar 2025
By 2030, orphan drugs will make up a fifth of the forecast $1.6 trillion in worldwide prescription drug sales – a share that has doubled…
Blog
25 Feb 2025
Formal training is essential for stakeholder teams looking to enhance their forecasting expertise. By deepening their understanding of fundamental principles, methodologies, and process steps, teams…
Infographic
2 Jan 2025
Will the much-awaited biopharma recovery finally arrive in the coming year? This infographic provides key data from our 2025 Preview report, giving you a quick…
Catch up with our latest forecasting webinars
Webinar
Thursday 21st November 3pm GMT | 10am EST
